1.
Stumvoll M, Goldstein BJ, van Haeften TW. Type 2diabetes: principles of pathogenesis and therapy. Lancet.2005;365(9467):1333-1346.
2.
Rivellese AA, Riccardi G, Vaccaro O. Cardiovascular risk inwomen with diabetes. Nutr Metab Cardiovasc Dis. 2010;20(6):474-480.
3.
Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: astatement by the American Diabetes Association. Diabetes Care.2005;28(4):956-962.
4.
Verrier RL, Antzelevitch C. Autonomic aspects ofarrhythmogenesis: the enduring and the new. Curr Opin Cardiol.2004;19(1):2-11.
5.
Kluppelholz B, Thorand B, Koenig W, et al. Association ofsubclinical inflammation with deterioration of glycaemiabefore the diagnosis of type 2 diabetes: the KORA S4/F4 study.Diabetologia. 2015;58(10):2269-2277.
6.
Aburisheh K, AlKheraiji MF, Alwalan SI, et al. Prevalence of QTprolongation and its risk factors in patients with type 2 diabetes.BMC Endocr Disord. 2023;23(1):50.
7.
Cox AJ, Azeem A, Yeboah J, et al. Heart rate-corrected QT intervalis an independent predictor of all-cause and cardiovascularmortality in individuals with type 2 diabetes: the Diabetes HeartStudy. Diabetes Care. 2014;37(5):1454-1461.
8.
Naas AA, Davidson NC, Thompson C, et al. QT and QTcdispersion are accurate predictors of cardiac death in newlydiagnosed non-insulin dependent diabetes: cohort study. BMJ.1998;316(7133):745-746.
9.
Tokatli A, Kiliçaslan F, Alis M, Yiginer O, Uzun M. ProlongedTp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patientswith Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul).2016;31(1):105-112.
10.
Kuzu F. The effect of type 2 diabetes on electrocardiographicmarkers of significant cardiac events. Pak J Med Sci.2018;34(3):626-632.
11.
Yamaguchi M, Shimizu M, Ino H, et al. T wave peak-to-endinterval and QT dispersion in acquired long QT syndrome: a newindex for arrhythmogenicity. Clin Sci. 2003;105(6):671-676.
12.
Dahlberg P, Diamant UB, Gilljam T, Rydberg A, Bergfeldt L.QT correction using Bazett’s formula remains preferable in longQT syndrome type 1 and 2. Ann Noninvasive Electrocardiol.2021;26(1):e12804.
13.
Svane J, Pedersen-Bjergaard U, Tfelt-Hansen J. Diabetes and theRisk of Sudden Cardiac Death. Curr Cardiol Rep. 2020;22(10):112.
14.
Ninkovic VM, Ninkovic SM, Miloradovic V, et al. Prevalenceand risk factors for prolonged QT interval and QT dispersion inpatients with type 2 diabetes. Acta Diabetol. 2016;53(5):737-744.
15.
Stern K, Cho YH, Benitez-Aguirre P, et al. QT interval, correctedfor heart rate, is associated with HbA1c concentration andautonomic function in diabetes. Diabet Med. 2016;33(10):1415-1421.
16.
Ninkovic VM, Ninkovic SM, Miloradovic V, et al. Prevalenceand risk factors for prolonged QT interval and QT dispersion inpatients with type 2 diabetes. Acta Diabetol. 2016;53(5):737-744.doi:10.1007/s00592-016-0864-y
17.
Agarwal G, Singh SK. Arrhythmias in type 2 diabetes mellitus.Indian J Endocrinol Metab. 2017;21(5):715-718.
18.
Castro-Torres Y, Carmona-Puerta R, Katholi RE. Ventricularrepolarization markers for predicting malignant arrhythmias inclinical practice. World J Clin Cases. 2015;16:3(8):705-720.
19.
Ardahanlı İ, Celik M. Comparison of Tp-e interval, QTc intervaland Tp-e/QTc ratios between non-diabetic and prediabeticpopulation. Ann Med Res. 2020; 27(12):3117-3122.
20.
Fox CS, Sullivan L, D’Agostino RB Sr, Wilson PW; FraminghamHeart Study. The significant effect of diabetes duration oncoronary heart disease mortality: the Framingham Heart Study.Diabetes Care. 2004;27(3):704-708.
21.
Kishi S, Gidding SS, Reis JP, et al. Association of insulin resistanceand glycemic metabolic abnormalities with LV structure andfunction in middle age: the CARDIA Study. JACC CardiovascImaging. 2017;10(2):105-114.
22.
Haffner SM, Mitchell BD, Stern MP, Hazuda HP. Macrovascularcomplications in Mexican Americans with type II diabetes.Diabetes Care. 1991;14(7):665-671.
23.
Waheed S, Dawn B, Gupta K. Association of corrected QTinterval with body mass index, and the impact of this associationon mortality: results from the third national health and nutritionexamination survey. Obes Res Clin Pract. 2017;11(4):426-434.
24.
Bağcı A, Aksoy F. The frontal plane QRS-T angle may affect ourperspective on prehypertension: a prospective study. Clin ExpHypertens. 2021;43(5):402-407.
25.
Csige I, Ujvárosy D, Szabó Z, et al. The impact of obesity on thecardiovascular system. J Diabetes Res. 2018;2018:3407306.
26.
Lambert EA, Straznicky NE, Dixon JB, Lambert GW. Shouldthe sympathetic nervous system be a target to improvecardiometabolic risk in obesity? Am J Physiol Heart CirculatoryPhysiol. 2015;309(2):H244-H58.